×
0.0196078431372548 0.0784313725490195 0.137254901960784 0.0980392156862745 0.130862745098039 0.110980392156863 0.156862745098039 0.309803921568627
Stockreport

Adamis Pharmaceuticals Updates Symjepi Commercialization Plans

ADAMIS PHARMACEUTICALS (ADMP)  More Company Research Source: GlobeNewswire
Last adamis pharmaceuticals earnings: 11/9 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.adamispharmaceuticals.com/investor-overview
PDF SAN DIEGO, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today provided an update on the progress of exploring commercialization options relating to the commercial launch of its SymjepiTM (epinephrine) Injection 0.3mg product, for the emergency treatment of allergic reactions (Type I) including anaphylaxis. Dr. Dennis J. Carlo, President and CEO of Adamis, stated, “As reflected in our previous statements, since receiving FDA approval last year we have engaged in a confidential process with the goal to maximize the value of this asset, including seeking a commercial partner to launch Symjepi in the U.S. I know many investors have become frustrated with the time that this process has taken. I too am frustrated that the process is taking longer than we initially expected. However, this process has been neither simple nor linear. We remain committed to bringing Symjepi to the market.” “While the process is still ongoing, we are now in discussions w [Read more]

IMPACT SNAPSHOT EVENT TIME: ADMP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ADMP alerts
from News Quantified
Opt-in for
ADMP alerts

from News Quantified
Opt-in for
ADMP alerts

from News Quantified